Vensana Capital Discloses 9.9% Stake in SpyGlass Pharma Post-IPO, Including Director Nielsen
SGP is trading near its 52-week low of $24.71 (5.9% above the low).
Summary
Vensana Capital, an early investor, filed an initial Schedule 13D disclosing a 9.9% beneficial ownership in SpyGlass Pharma following its recent IPO, with Director Kirk Nielsen also reporting beneficial ownership through the fund.
Key Events · Ownership and Investor Activity · SGP
-
Initial 13D Filing Post-IPO
Vensana Capital I, L.P., Vensana Capital I GP, LLC, and their managing directors Kirk Nielsen (a board member) and Peter Justin Klein, filed their initial Schedule 13D.
-
Significant Ownership Stake
The reporting group beneficially owns 3,310,619 shares, representing 9.9% of SpyGlass Pharma's common stock outstanding after the recent initial public offering.
-
IPO Participation and Conversion
Vensana I purchased 165,000 shares of common stock in the IPO for $2.64 million, and its previously held preferred stock automatically converted into common stock upon the IPO's closing on February 9, 2026.
-
Lock-Up Agreement in Place
Vensana I has entered into a standard 180-day lock-up agreement, restricting the sale or transfer of its shares following the IPO.
Analysis · SGP · Industrial Applications And Services
This initial Schedule 13D filing provides crucial transparency into SpyGlass Pharma's post-IPO ownership structure, revealing a substantial 9.9% stake held by Vensana Capital and its managing directors, including board member Kirk Nielsen. This disclosure confirms significant institutional backing from a venture capital firm that has been an early investor in the company. The participation in the IPO and the standard lock-up agreement signal continued commitment and a long-term investment horizon, which can be viewed positively by the market for a newly public company.
How filings like this one have moved
In the 30 days to Aug 23, 2026, 37.4% of the 3405 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SGP was trading at $26.18 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $835.4M. The 52-week trading range was $24.71 to $28.44. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.